Document Detail


Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.
MedLine Citation:
PMID:  18549841     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Results of well-controlled prospective clinical trials showed the efficacy of lipid-lowering therapies in the reduction of cardiovascular (CV) events in western populations, but they were not reported with a Chinese population. This multicenter study was conducted to determine the effects of Xuezhikang (XZK), a partially purified extract of red yeast rice, on lipoprotein and CV end points in Chinese patients who experienced a previous myocardial infarction. Nearly 5,000 of these patients with average low-density lipoprotein cholesterol levels at baseline were randomly assigned either to placebo or to XZK daily for an average of 4.5 years. The primary end point was a major coronary event that included nonfatal myocardial infarction and death from coronary heart disease. Frequencies of the primary end point were 10.4% in the placebo group and 5.7% in the XZK-treated group, with absolute and relative decreases of 4.7% and 45%, respectively. Treatment with XZK also significantly decreased CV and total mortality by 30% and 33%, the need for coronary revascularization by 1/3, and lowered total and low-density lipoprotein cholesterol and triglycerides, but raised high-density lipoprotein cholesterol levels. In conclusion, long-term therapy with XZK significantly decreased the recurrence of coronary events and the occurrence of new CV events and deaths, improved lipoprotein regulation, and was safe and well tolerated.
Authors:
Zongliang Lu; Wenrong Kou; Baomin Du; Yangfeng Wu; Shuiping Zhao; Osvaldo A Brusco; John M Morgan; David M Capuzzi; ; S Li
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2008-04-11
Journal Detail:
Title:  The American journal of cardiology     Volume:  101     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-06-13     Completed Date:  2008-07-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1689-93     Citation Subset:  AIM; IM    
Affiliation:
Fuwai Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, Peoples Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Biological Products / pharmacology*
China / epidemiology
Cholesterol, LDL / blood*,  drug effects
Dietary Supplements
Double-Blind Method
Drugs, Chinese Herbal / administration & dosage,  pharmacology*,  therapeutic use
Female
Follow-Up Studies
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hyperlipoproteinemias / blood,  drug therapy*,  epidemiology
Male
Middle Aged
Morbidity / trends
Myocardial Infarction / epidemiology,  prevention & control*
Prospective Studies
Survival Rate / trends
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Biological Products; 0/Cholesterol, LDL; 0/Drugs, Chinese Herbal; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/red yeast rice; 0/xuezhikang
Investigator
Investigator/Affiliation:
Y S Xu / ; D F Gu / ; X Jia / ; Z Chen / ; J L Sun / ; J Chen / ; X H Yu / ; J H Wang / ; N Wang / ; R P Zheng / ; S H Zhang / ; C X Liu / ; L H Sun / ; Y C Zhao / ; Y Lin / ; J B Huang / ; D Y Hu / ; X C Yang / ; Y Z Liu / ; M M Gao / ; P Zhang / ; C X Deng / ; Y Liu / ; Z Q Li / ; Y Q Shi / ; T S Hu / ; Y Z Chen / ; S Tan / ; W R Zhao / ; G L Deng / ; W J Huang / ; J C Zhang / ; H Yu / ; Q S Shi / ; X Z Wang / ; B Jiang / ; X R Pan / ; L Li / ; P L Pu / ; M Q Shu / ; Q L Xu / ; J H Zhang / ; W H Ding / ; L Li / ; J J Yang / ; J L Su / ; W D Zhao / ; X Liu / ; L J Li / ; J F Yang / ; Q S Wang / ; T G Huang / ; L F Li / ; L J Zhou / ; J X Guo / ; W H Li / ; Z P Li / ; X G Zhang / ; X M Peng / ; Y W An / ; J Shu / ; L T Ma / ; H Ge / ; M J Zhang / ; Z R Lv / ; J H Li / ; J W Yang / ; L Zhang / ; Y L Cheng / ; J G Chen / ; C W Zhou / ; H H Zhang / ; Y L Huang / ; X F Qu / ; J J Li / ; H Guo / ; G X Wang / ; S Z Hao / ; S J Li / ; H S Chang / ; S M Zhou / ; H Q Liang / ; S J Cao / ; J G Liu / ; J Yang / ; M Y Zhao / ; Y Lv / ; S L Xu / ; Z L Wang / ; S P Zhao / ; X P Li / ; X L Luo / ; Y P Li / ; Y Lei / ; S Q Fan / ; L H Wang / ; L J Zhao / ; Y C Zhao / ; S W Xue / ; J Li / ; S Y Xu / ; Y G Cao / ; B G Tong / ; W Wang / ; S K Xu / ; H Z Chen / ; W L Guo / ; L J Wang / ; X M Yan / ; X F Jing / ; C H Wang / ; B X Tang / ; H Bai / ; L Li / ; Y Liu / ; Y P Li / ; F Mei / ; K Z Yuan / ; Y Zhang / ; Y R Sun / ; L Chen / ; S R Xue / ; J P Wang / ; B Li / ; Z M Liu / ; L H Shen / ; J R Liang / ; Y Zhang / ; Y L Song / ; Y M Sun / ; Z Wang / ; Y H Xu / ; W J Zhang / ; R Q Mu / ; K Q Li / ; Y P Wei / ; S M Wang / ; Y J Fan / ; K Y An / ; J Guo / ; A P Li / ; D Y Zeng / ; H Y Huo / ; Y Chen / ; L X Song / ; B Q Jiang / ; D J Guo / ; H Chen / ; L Li / ; Y Q Yin / ; Y M Mao / ; L Miao / ; Y J Guo / ; S J Li / ; S S Cui / ; Q Diao / ; X M You / ; B Jiang / ; L T Zhu / ; J M Liu / ; L Fang / ; S G Lin / ; L Y Chen / ; W H Huang / ; Z G Zheng / ; Y N Ke / ; Y Wang / ; Q S Wang / ; H Liang / ; R Y Jia / ; T Wang / ; C X Liu / ; Q J Gen / ; B X Duan / ; C Q Fang / ; J Y Wang / ; Z W Chang / ; Y Qi / ; X Wang / ; W S He / ; P Ye / ; Y C Liu / ; C L Li / ; J J Ye / ; B X He / ; X Y Zhang / ; X F Hong / ; R G Shi / ; W L Wei / ; J J Sun / ; Z C Li / ; X J Zhang / ; P He / ; W Gao / ; Y J He / ; H B Zhang / ; N D Li / ; X N He / ; G L Chen / ; J L Wang / ; G F Liang / ; G Z Dai / ; Q Wang / ; H Y Jin / ; Y Li / ; L P Wei / ; L Qiao / ; S S Gao / ; S Wang / ; Q Fang / ; S Q Tao / ; Z J Chen / ; L S Gong / ; J Z Li / ; Y S Xu / ; B Q Jiang / ; L H Shen / ; S L Liang / ; Y L Huang / ; Y Z Chen / ; Z R Lu / ; W R Kou / ; Z L Wang / ; G Z Dai / ; J H Zhang / ; J X Guo / ; D Y Zeng / ; S G Lin / ; B X He / ; Y F Wu / ; X G Wu / ; J L Wang / ; Z L Lu / ; W R Kou / ; B M Du / ; Y F Wu / ; Y Li / ; X W Qin / ; B L Chen /

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cholesterol ester transfer protein, interleukin-8, peroxisome proliferator activator receptor alpha,...
Next Document:  Impact of individual and cumulative coronary risk factors on coronary flow reserve assessed by dobut...